| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/07/2008 | US20080188505 Applying agmatine and a dermatologically acceptable carrier to the skin; inhibiting hair growth |
| 08/07/2008 | US20080188485 4-piperazine-4-piperidine-1-ketone derivatives; graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 08/07/2008 | US20080188476 Comprises zonisamide (anticonvulsant) in combination with bupropion for enhancing activity of norepinephrine and/or dopamine via uptake inhibition; side effect reduction |
| 08/07/2008 | US20080188425 Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods |
| 08/07/2008 | US20080188417 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 08/07/2008 | US20080188402 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 08/07/2008 | US20080187994 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; immunotherapy |
| 08/07/2008 | US20080187961 Polynucleotides encoding signal peptide-containing molecules |
| 08/07/2008 | US20080187573 Pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase b inhibitor component |
| 08/07/2008 | US20080187553 Immunstimulating lipid formulation |
| 08/07/2008 | US20080187551 Nucleotide sequences coding oncogenic polypeptides for use in generating vaccines to prevent and treat cell proliferative disorders; genetic vaccines |
| 08/07/2008 | US20080187550 Using bacterial dnaJ chaperone protein sequences as agent to enhance immune respone; for use in treatment and prevention of arthritic inflammation |
| 08/07/2008 | US20080187540 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 08/07/2008 | US20080187538 Posh nucleic acids, polypeptides and related methods |
| 08/07/2008 | US20080187533 Treatment with anti-erbb2 antibodies |
| 08/07/2008 | US20080187514 Using hematopoietic stem cells to restore functional and structural integrity to damaged myocardium; tissue engineering; tissue repair; regenerative medicine |
| 08/07/2008 | DE10132669B4 Pharmakologische Zubereitung aus einem nanopartikulären mesomorphen Polyelektrolyt-Lipid-Komplex und mindestens einem Wirkstoff Pharmacological preparation of a nanoparticulate mesomorphic polyelectrolyte-lipid complex and at least one active ingredient |
| 08/07/2008 | CA2676168A1 Pharmaceutical compositions and methods of using temozolomide and multi-targeted kinase inhibitors |
| 08/07/2008 | CA2676138A1 Compounds and compositions as kinase inhibitors |
| 08/06/2008 | EP1953243A2 Polynucleotides related to colon cancer |
| 08/06/2008 | EP1953173A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
| 08/06/2008 | EP1953147A1 Heterocyclic compound and medicinal application thereof |
| 08/06/2008 | EP1952824A1 Compositions and methods of treatment using L-type calcium channel blockers and cholinesterase inhibitors |
| 08/06/2008 | EP1952819A2 Method for preventing gastritis using amylin or amylin agonists |
| 08/06/2008 | EP1952700A1 Method of improving absorption of vitamin E by a pet animal |
| 08/06/2008 | EP1951309A2 Combination of an angiotensin ii receptor blocker, a calcium channel blocker and another active agent |
| 08/06/2008 | EP1951308A1 Combination preparations containing physiological cell membrane constituents including phosphatidylserine, choline and a pyrimidine nucleoside/nucleotide |
| 08/06/2008 | EP1951307A2 Combination of a cdk-inhibitor and a hdac-inhibitor |
| 08/06/2008 | EP1951264A2 Use of cicletanine and other furopyridines for treatment of hypertension |
| 08/06/2008 | EP1951250A2 Chemical compounds |
| 08/06/2008 | EP1951248A2 Novel colored solutions of injectable drugs and their pharmaceutically acceptable salts |
| 08/06/2008 | EP1951246A2 Method of preventing oral staining |
| 08/06/2008 | EP1951245A2 Pharmaceutical compositions comprising methotrexate |
| 08/06/2008 | EP1951242A2 Combination therapy for the treatment of cancer |
| 08/06/2008 | EP1951231A2 Camptothecin derivatives as chemoradiosensitizing agents |
| 08/06/2008 | EP1951213A1 Use of alpha-hydroxy carbonyl compounds as reducing agents |
| 08/06/2008 | EP1951212A2 Compositions and methods for increasing insulin sensitivity |
| 08/06/2008 | EP1737467A4 Method and composition for treatment of skin conditions |
| 08/06/2008 | EP1641455B1 Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors |
| 08/06/2008 | EP1592388A4 Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin |
| 08/06/2008 | EP1516061B1 Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor |
| 08/06/2008 | EP1432714B1 Chemical compounds |
| 08/06/2008 | EP1385523B1 Adenosine a1 receptor antagonists for treating hypoxia-induced learning and memory impairment |
| 08/06/2008 | EP1366059B1 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 08/06/2008 | EP1257819B1 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels |
| 08/06/2008 | EP1257298B1 Cosmid dna constructs and methods of making and using the same |
| 08/06/2008 | EP1237575B1 Tnf-alpha antagonist and lfa-1 antagonist for treating rheumatoid arthritis |
| 08/06/2008 | EP1192277B1 Diagnosis of restenosis |
| 08/06/2008 | EP1173757B1 Diagnosis of human kidney diseases |
| 08/06/2008 | EP1163002B1 Polycationic carbohydrates as immunostimulants in vaccines |
| 08/06/2008 | EP1147133B1 Peptides consisting of two PTH functional domains fused by a linker molecule, and derivatives thereof |
| 08/06/2008 | EP1133284B2 A process for the preparation of crystalline particles |
| 08/06/2008 | EP1127168B1 Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis |
| 08/06/2008 | EP1015884B1 Methods of identifying molecules that home to angiogenic vasculature in tumors |
| 08/06/2008 | CN101238370A Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin |
| 08/06/2008 | CN101237886A Compositions for affecting weight loss |
| 08/06/2008 | CN101237885A Agent for regeneration and/or protection of nerves |
| 08/06/2008 | CN101237884A Int6 protein involved in hypoxia stress induction and use thereof |
| 08/06/2008 | CN101237878A Intralesional treatment of psoriasis |
| 08/06/2008 | CN101237870A Concomitant pharmaceutical agents and use thereof |
| 08/06/2008 | CN101234201A High molecule impregnation implantation sustained-release drug delivering system and preparation thereof |
| 08/06/2008 | CN101234200A Composition for improving and treating human body digestive system a plurality of malaise symptoms |
| 08/06/2008 | CN101234123A Application of certain concentration hydrochloric acid water for treating blood vessel disease |
| 08/06/2008 | CN101234086A Hydroxycamptothecin containing anti-cancer sustained-release injection |
| 08/06/2008 | CN101234085A Docetaxel-containing anti-cancer sustained-release injection |
| 08/06/2008 | CN101234084A Fluorouracil containing anti-cancer sustained-release injection |
| 08/06/2008 | CN101234082A Sustained-release injection containing angiogenic inhibitor votaranib |
| 08/06/2008 | CN101234081A Sustained-release injection containing angiogenic inhibitor |
| 08/06/2008 | CN101234080A Sustained-release injection containing angiogenic inhibitor and synergistic agent thereof |
| 08/06/2008 | CN100408694C Transcription active test |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408567C Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 08/06/2008 | CN100408100C Ophthalmic compositions containing galactomannan polymers and borate |
| 08/06/2008 | CN100408093C Use of inhibitor of angiotonin converzyme in preparing pharmaceutical formulations for prevention of stroke, diabetes and/or congestive heart failure |
| 08/06/2008 | CN100408035C Use of valsartan or its metabolite to inhibit platelet aggregation |
| 08/05/2008 | US7408046 Administering anticarcinogenic agent and chelate complex of macrocyclic aminophosphonic acid and radionuclide such as samarium ethylenediaminetetramethylenephosphonic acid (EDTMP) to replace total body irradiation;antiproliferative agents; autoimmune, infectious, metabolic or genetic disorders |
| 08/05/2008 | US7408044 Carrier protein having an adjuvant effect |
| 08/05/2008 | US7408036 Human voltage gated sodium channel β1A subunit and methods of use |
| 08/05/2008 | US7408025 Bactericides; peptide antibiotic |
| 08/05/2008 | US7407987 Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| 08/05/2008 | US7407986 Administering a isothiocyanate, such as sulforaphane, or a glucosinolate; retinal degeneration, Alzheimer's Disease, and aging |
| 08/05/2008 | US7407944 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends |
| 08/05/2008 | US7407934 Controlling blood glucose concentration; amylin antagonist such as 25,28,29Pro-h-amylin, pramlintide; reducing gastric motility and delaying gastric emptying |
| 08/05/2008 | US7407932 Exendin agonist composed of a peptide in which at least one amino acid residue is acylated with a dicarboxylic acid; the amino acid residues are an internal lysine residue, an N-terminal amino acid residue, and/or a C-terminal amino acid residue; treatment of glucagonoma |
| 08/05/2008 | US7407931 Administering an hematopoietic colony stimulating factors of sargramostim; Crohn's Disease |
| 08/05/2008 | US7407805 Keratinocytes and culture medium containing ascorbic and linoleic acid, vitamin e, epidermal growth factor; has surface electrical capacitance of given values |
| 08/05/2008 | US7407772 Screening and selection methods for statin drug combinations |
| 08/05/2008 | US7407767 Treating dilated cardiomyopathy by removing anti-cardiac troponin autoantibody from patient's blood |
| 08/05/2008 | US7407766 Screening method for agonists or antagonists of semaphorin 6C by determining the effect of a test compound on the interaction between semaphorin 6C and plexin-A1 |
| 08/05/2008 | US7407675 Anti-neoplastic compositions comprising extracts of black cohosh |
| 08/05/2008 | US7407669 film delivers at least one oral care agent, such as antimicrobial agents and salivary stimulants |
| 08/05/2008 | US7407663 Modified immunodeficiency virus particles |
| 08/05/2008 | US7407661 Methods and reagents that generate a CD8 T cell immune response |
| 08/05/2008 | US7407654 From fermentation of Streptomyces; bactericides |
| 08/05/2008 | US7407651 IFN-β liquid formulations |
| 08/05/2008 | CA2464250C Kit for the preparation of a pharmaceutical composition |
| 08/05/2008 | CA2398035C Timed pulsatile drug delivery systems |
| 08/05/2008 | CA2334577C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/05/2008 | CA2324265C Liquid polymeric compositions for controlled release of bioactive substances |
| 07/31/2008 | WO2008092103A2 Combination cancer treatments comprising elsamitrucin and other agents |